Showing results (1871-1880 of 4,401) with videos related to

Sort By:
Pageof 441
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Compounds as Emopamil-Binding Protein Inhibitors for Treating Multiple SclerosisRam W Sabnis
ACS Medicinal Chemistry Letters|August 20, 2025
Discovery and Characterization of Novel FGFR1 V561M Inhibitors via Virtual Screening and Molecular Dynamics SimulationsYang Lu, Bizhi Li, Xiaoli Zheng, et al.
ACS Medicinal Chemistry Letters|March 16, 2023
Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing ApproachMinh H Nguyen, Hai-Fen Ye, Yao Xu, et al.
ACS Medicinal Chemistry Letters|February 16, 2023
Plasma Kallikrein Inhibitors as Potential Treatment for Diabetic Macular Edema, Retinal Vein Occlusion, Hereditary Angioedema and Other Related DiseasesAhmed F Abdel-Magid
ACS Medicinal Chemistry Letters|November 17, 2022
Discovery of 5,7-Dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones as Highly Selective CDK2 InhibitorsAlexander Sokolsky, Sarah Winterton, Keith Kennedy, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Optimization of Pyrimidine Compounds as Potent JAK1 Inhibitors and the Discovery of R507 as a Clinical CandidateYan Chen, Hui Li, Rose Yen, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Novel TYK2 Inhibitors with an N-(Methyl-d 3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune DiseasesFei Liu, Bin Wang, Yanlong Liu, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD KinaseTonghai Liu, Wenjia Shi, Yiluan Ding, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding ModeStacey M Southall, Joydeep Banerjee, Jason Brown, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Covalent Modification of the JH2 Domain of Janus Kinase 2Sean P Henry, Maria-Elena Liosi, Joseph A Ippolito, et al.
Pageof 441